The NHS will save £7 billion by the end of 2023 after a 5-year agreement with the pharmaceutical industry. The voluntary scheme for branded medicines pricing and access, was introduced in 2019 to keep the branded medicine bill affordable for the NHS by capping the growth of sales, while improving patient access to medicines by getting new medicines into use more quickly and supporting our life sciences sector.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.
Networks can be open to all or available only to a closed group defined by the administrator.
Join or create a network here.
